Capital Access Advisory Program — Building Companies
At a glance
- No Condition
- Open Date : August 01, 2022
- Closing date : August 06, 2023
- Health care and social assistance
- Ontario Bioscience Innovation Organization
Overview
Eligibility criteria
Eligibility criteria for OBIO’s CAAP® grant:
- Health science companies seeking to raise Series A financing in the Q4 2023 to 2024 timeframe
Who is eligible
There are eligible types of companies for the OBIO® Capital Access Advisory Program:
- Health science companies seeking Series A financing
- Companies starting to raise funding in Q4 2023 to 2024
Eligible expenses
There are eligible expenses for this grant:
- Technology commercialization expenses
- Business development costs
- Fundraising-related expenses
- Negotiation costs
Evaluation & selection criteria
There are evaluation and selection criteria for the OBIO CAAP® grant program:
- Demonstrated potential for technology commercialization and scalability
- Evidence of business strategic planning and market feasibility
- Ability to articulate advanced fundraising strategies and financial modeling
- Clear plan for closing an investment round
How to apply
- Step 1: Review the eligibility criteria on the OBIO website
- Content: Check if your health science company aligns with the program requirements
- Implications: Ensures your company meets the necessary qualifications
- Step 2: Prepare your application materials
- Content: Gather the requested documents and information for the application
- Implications: Demonstrates your readiness and commitment to the program
- Step 3: Submit your application within the specified deadline
- Content: Complete the online application form as per instructions
- Implications: Ensures your consideration for the CAAP program
OBIO Capital Access Advisory Program (CAAP®)
The OBIO® Capital Access Advisory Program (CAAP®) is a competitive 9-month structured program designed for health science companies aiming to raise Series A financing between Q4 2023 and 2024. CAAP® focuses on business strategic planning, advanced fundraising strategies, and closing investment rounds, providing companies with strategic guidance, network access to advisors, and investor readiness, culminating in a presentation at the OBIO Investment Summit.
Detailed Explanation of OBIO's CAAP®
The OBIO Capital Access Advisory Program (CAAP®) is a specialized program geared towards accelerating technology commercialization in the health science sector. The program offers a targeted approach for companies looking to secure Series A financing within a specific timeframe, covering essential business themes to enhance investor returns and optimize fundraising strategies.
CAAP® participants benefit from the guidance of an international Steering Committee comprising investors, healthcare executives, and business experts. This committee provides invaluable insights on positioning the companies for successful fundraising efforts, leveraging their collective expertise to drive strategic growth and investor interest.
Moreover, CAAP® facilitates access to a network of advisors with diverse proficiencies in technology commercialization, business development, fundraising, and negotiation skills. By tapping into this extensive network, companies can refine their investor targeting strategies, refine their messaging, and establish meaningful connections in the industry.
One of the key highlights of the program is the opportunity for companies to present at the prestigious OBIO Investment Summit. This platform allows CAAP® participants to showcase their innovations to a global audience of health sciences investors and strategic partners, creating a pathway for potential investments and collaborations.
Over the years, the OBIO Investment Summit has proven to be a catalyst for raising capital, with companies collectively raising over $1.3 billion since 2018. With a track record of featuring 160 companies at the Summit, CAAP® provides a significant springboard for participating companies to elevate their visibility, attract investment, and forge strategic alliances in the health science ecosystem.
In conclusion, OBIO's CAAP® is a comprehensive program that not only equips companies with the tools and knowledge to navigate the complexities of fundraising and strategic planning but also serves as a gateway to high-value opportunities in the health science industry. By participating in CAAP®, companies can accelerate their path to Series A financing, gain invaluable insights from industry experts, and position themselves for long-term success in the competitive landscape of health science innovation.
